Nanoparticles Dysregulate the Human Placental Secretome with Consequences on Angiogenesis and Vascularization

Autor: Battuja Dugershaw‐Kurzer, Jonas Bossart, Marija Buljan, Yvette Hannig, Sarah Zehnder, Govind Gupta, Vera M. Kissling, Patrycja Nowak‐Sliwinska, Judy R. vanBeijnum, Arjan W. Griffioen, Stefan Masjosthusmann, Etta Zühr, Ellen Fritsche, René Hornung, Thomas Rduch, Tina Buerki‐Thurnherr

Publikováno v: Advanced Science, Vol 11, Iss 28, Pp n/a-n/a (2024)

Abstract Exposure to nanoparticles (NPs) in pregnancy is increasingly linked to adverse effects on embryo‐fetal development and health later in life. However, the developmental toxicity mechanisms of NPs are largely unknown, in particular potential

Externí odkaz: https://doaj.org/article/2a31beb452ae480abf4e8493d6d513f5

Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry

Autor: Jonas Bossart, Christian P. Kamm, Marco Kaufmann, Mina Stanikić, Milo A. Puhan, Jürg Kesselring, Chiara Zecca, Claudio Gobbi, Irene Rapold, Roland Kurmann, Sabin Ammann, Viktor von Wyl

Publikováno v: Bossart, Jonas; Kamm, Christian P; Kaufmann, Marco; Stanikić, Mina; Puhan, Milo A; Kesselring, Jürg; Zecca, Chiara; Gobbi, Claudio; Rapold, Irene; Kurmann, Roland; Ammann, Sabin; von Wyl, Viktor (2022). Real-world disease-modifying therapy usage in persons with relapsing-remitting multiple sclerosis: Cross-sectional data from the Swiss Multiple Sclerosis Registry. Multiple Sclerosis and Related Disorders, 60, p. 103706. Elsevier 10.1016/j.msard.2022.103706

INTRODUCTION Several disease-modifying therapies (DMTs), covering a broad spectrum of mechanisms of action, have been approved by regulatory agencies for the treatment of relapsing-remitting multiple sclerosis (RRMS). However, only little is known ab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bfe8b5d040c087ab590e666662bcce7
https://www.zora.uzh.ch/id/eprint/226942/